Veru Inc VE/BAIIA
Quel est le VE/BAIIA de Veru Inc?
Le VE/BAIIA de Veru Inc est N/A
Quelle est la définition de VE/BAIIA?
VE/BAIIA est la valeur de l’entreprise divisée par le bénéfice avant intérêts, impôts, dépréciations et amortissements. Il s'agit d'une mesure du coût d'une action et est plus souvent valable pour des comparaisons entre sociétés que le ratio cours / bénéfice. Il mesure le prix (sous forme de valeur d'entreprise) qu'un investisseur paie au profit des flux de trésorerie de l'entreprise (sous forme de BAIIA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
VE/BAIIA des entreprises dans Health Care secteur sur NASDAQ par rapport à Veru Inc
Que fait Veru Inc?
the female health company/veru healthcare is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. to realize this goal, veru healthcare has three divisions: pharmaceutical and devices, consumer health products, and public sector. for men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout, and sexual dysfunction. women’s health has product candidates for female sexual health and advanced breast and ovarian cancers and markets fc2, a disposable contraceptive device, to ob gyn physicians and is the only female condom approved by fda that offers dual protection against sexually transmitted infections, including hiv/aids and the zika virus, and unintended pregnancy. since the female health company began distributing fc2 in 2007, the product has been shipped to 144 countries
Entreprises avec ve/baiia similaire à Veru Inc
- Annovis Bio a VE/BAIIA de N/A
- Newtopia a VE/BAIIA de N/A
- Branded Legacy Inc a VE/BAIIA de N/A
- 23228 a VE/BAIIA de N/A
- Centurion Minerals a VE/BAIIA de N/A
- URA Plc a VE/BAIIA de N/A
- Veru Inc a VE/BAIIA de N/A
- Dynamo Capital a VE/BAIIA de N/A
- Esports Mogul a VE/BAIIA de N/A
- FireFox Gold a VE/BAIIA de N/A
- SecureWorks Corp a VE/BAIIA de N/A
- Armada Metals Ltd a VE/BAIIA de N/A
- BriaCell Therapeutics a VE/BAIIA de N/A